A1. At-risk stage (50%), one affected parent |
- Anxiousness for the future |
|
|
- Uncertainty about carriership |
|
|
- Care for affected parent |
|
|
|
|
A2.Gene carrier, premanifest stage |
- Certainty about carriership |
|
|
- New position in the family |
|
|
- Renewed uncertainty about onset |
|
|
- Care for affected parent and own family |
|
|
|
|
A3. Transition phase |
- Strong feelings about changes in cognition |
|
|
- Changes in behaviour |
|
|
- Changes in motor activity |
|
|
- Uncertainty remains |
|
|
|
|
B. Clinical stage |
|
|
B1. Clinical stage I |
- Presentation first symptoms: neurological, cognitive or psychiatric |
|
|
- Chorea most prominent symptom |
|
|
- Independent in ADL |
|
|
- Burden for the family mainly psychological |
|
|
- Rare death, unless suicide |
|
|
|
|
B2 Clinical stage II |
- Motor disturbance more generalised |
|
|
- Physical dependence starts |
|
|
- Burden for family psychological and physical |
|
|
- Death by other cause, suicide, euthanasia |
|
|
|
|
B3. Clinical stage III |
- Severe generalised motor disturbance |
|
|
- Almost complete physical dependence |
|
|
- Patient completely dependent on care |
|
|
- Burden for family mainly physical |
|
|
- Death |